Brief: Kinnevik Invests $75 Mln in Biotechnology Company Recursion

Kinnevik AB

25/10/2022 13:44

Oct 25 (Reuters) - Kinnevik AB  KINVb.ST :
    * LEADS USD 150 MILLION PRIVATE PLACEMENT IN RECURSION WITH
USD 75
MILLION INVESTMENT
    * HAS INVESTED USD 75M IN RECURSION, A US-BASED
CLINICAL-STAGE
BIOTECHNOLOGY COMPANY INDUSTRIALIZING DRUG DISCOVERY BY DECODING
BIOLOGY
    * WILL HOLD 7,653,061 SHARES OF CLASS A COMMON STOCK OF
COMPANY,
CORRESPONDING TO ECONOMIC OWNERSHIP STAKE OF ABOUT 4.2%

Source text for Eikon:  ID:nMFN4mCRXm 
Further company coverage:  KINVb.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))